ArticleClinical and translational radiation oncology2019

The GIRAFE phase II trial on MVCT-based "volumes of the day" and "dose of the day" addresses when and how to implement adaptive radiotherapy for locally advanced head and neck cancer.

Vincent Esteyrie et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.